Life Sciences News @ Gowlings

	Life Sciences News @ Gowlings
	February 10, 2012

Use Twitter? Follow Gowlings news on Twitter

U.S. Releases Draft Guidelines for Generic Biologic Drugs
http://www.bloomberg.com/news/2012-02-09/first-u-s-rules-for-generic-biotechnology-drugs-set-out-in-draft-proposal.html

Abbott invests 85 million euros to expand Irish plant
http://www.pharmatimes.com/Article/12-02-10/Abbott_invests_85_million_euros_to_expand_Irish_plant.aspx

New pathway proposed for Phase III trials in HIV
http://www.pharmatimes.com/Article/12-02-09/New_pathway_proposed_for_Phase_III_trials_in_HIV.aspx

Eisai gets bad news for Dacogen but excitement over Alzheimer study
http://www.pharmatimes.com/Article/12-02-10/Eisai_gets_bad_news_for_Dacogen_but_excitement_over_Alzheimer_study.aspx

Stem cells to be studied as fix for hearing loss in kids
http://www.ctv.ca/CTVNews/Health/20120210/stem-cells-cord-blood-hearing-loss-kids-120210/

Toilet training posters for Swansea University students
http://www.telegraph.co.uk/news/newstopics/howaboutthat/9074555/Toilet-training-posters-for-Swansea-University-students.html

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

© 2012 Gowling Lafleur Henderson LLP. All rights reserved.